Umeå Biotech Incubator (UBI) has received 2.5 million SEK from Kempestiftelserna for 2026 to support research verification activities. This funding aids commercialization for researchers, solidifying UBI's position as a leading biotech incubator in Europe.
Tobias Tovedal, a UBI business coach, becomes CEO of Patient Safety Surveillance Solutions (P3S), a KI startup developing software for monitoring healthcare-associated injuries. His leadership aims to enhance patient safety through real-time data analysis and expansion to more hospitals in Sweden.
Umeå Biotech Incubator has been awarded SEK 14.6 million in excellence funding by Vinnova, reaffirming its status as an excellent incubator. This funding, designated for 2025-2029, supports startups' growth, emphasizing sustainability and gender equality in business development.
HILICON, based in Umeå, has achieved record turnover and significant market presence in chromatography within ten years. CEO Wen Jiang aims to launch new products in 2025, expand the premises, and in the long term double the turnover while maintaining a focus on innovation and tailored customer solutions.
Urban Eriksson has been appointed Chairman of Umeå Biotech Incubator, bringing 30 years of leadership experience, notably as CEO of SLU Holding. He emphasizes the importance of bridging research and practical applications in life sciences for sustainable development.
Umeå based Nil Medical has developed an ergonomic, medical vest for children undergoing cancer treatment, allowing for greater mobility by concealing IV equipment within the garment. The vest is being evaluated in a national quality of life study, in collaboration with Swedish healthcare. Nil Medical aims to introduce the CE-marked "Vestpack" to the international market.
Christian Hedberg, a professor at Umeå University, is developing a revolutionary drug to treat cryptosporidiosis in animals and humans. He collaborates with France's INRAE and the treatment has shown promising results in ruminant models and has the potential to address a significant global health issue. Christian Hedberg has joined Umeå Biotech Incubator to bring the treatment to the market.
Umeå secures 1.8 million (22 SEK million) in EU funding for life science projects to boost innovation and industry growth. The project "Life Science City" is run by Umeå Biotech Incubator and seeks to expand the sector and strengthen collaborations. The SOLH project is a joint effort between Västerbotten and Norrbotten aiming to streamline and unify the innovation system.
Mucocort AB has received approval to start a clinical trial for an intraoral patch (M045A) to treat aphthous stomatitis, a condition causing mouth ulcers. The patch aims for immediate pain relief and healing promotion. The trial will be conducted in collaboration with Oral Care AB and produced by Aurena Laboratories AB in Sweden.
The Umeå Lab Fair, organized by Umeå Biotech Incubator, will take place on April 25th with 18 participating companies showcasing the latest developments in the life science industry. The new fair targets regional laboratory personnel and fills a gap in Umeå's event calendar. A Life Science Pub at Cinco will follow the fair, providing a networking opportunity for exhibitors and attendees.
Umeå Biotech Incubator has been named one of "Europe's leading Start-Up Hubs" by Financial Times, Statista, and Sifted. "This is an acknowledgment that our efforts are competitive, even globally," says Peter Jacobsson, UBI's operation coordinator.
Fredrik Almqvist and Marta Bally have been appointed as the new Directors of UCMR, the hub for microbial infection research at Umeå University. Their forward agenda includes enhancing collaboration with clinical research and establishing Biosafety Level 3 (BSL-3) labs for both in vitro and in vivo experiments.
Umeå Biotech Incubator (UBI) is inviting academic researchers and life science companies to meet and collaborate at its new ‘Open up for Innovation’ event on the 27th of February.
“We have world-class research being conducted at Umeå University and internationally successful companies based in town. Now we’re gathering 100 bright minds under one roof to stimulate innovation”, says Andreas
The response was overwhelming when Umeå Biotech Incubator launched the Quality Assurance network in Umeå this spring. The QA network brings together around 20 representatives from Life Science Umeå to exchange experiences and tackle the industry's increasingly complex quality requirements.
The AstraZeneca Exchange Nordic mentorship program provides expert advice to Nordic life science startups and entrepreneurs. For Umeå Biotech Incubator (UBI) the program has proven to be an invaluable tool for the startups it coaches - offering a range of advice from market and needs analysis to more specific technical questions.
Umeå Biotech Incubator has been granted SEK 14 million for the ERDF project "Life science city", which will further develop the life science industry in the region.
He has been a vital part of Umeå Biotech Incubator (UBI) since its inception in 2003. But now, after 42 years of service in the biotech industry, it is time for respected research engineer Assar Bäckman to retire. “My work has been hugely varied, and over the years I have learned a great deal. I usually have an emergency solution to most things if needed”, says Assar.
Experienced business coach Peter Jacobsson will now lead Umeå Biotech Incubator until a permanent replacement is appointed.
The Umeå Biotech Incubator-backed ‘Shades of Green’ project, developed by Boreal Orchards, has created a moss that can be used on buildings, infrastructure and for the regeneration of nature. Now founder Daniel Pacurar is collaborating on a new development project with RISE Processum AB and Ecohelix to maximize moss establishment with the help of by-products from the paper pulp industry.
Jennie Ekbeck, CEO of Umeå Biotech Incubator, has been awarded an honorary doctorate for 2023 at the Faculty of Science and Technology at Umeå University. “I want research to benefit people, that is my driving force,” she says.
Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.